GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Shiller PE Ratio
中文

OPKO Health (OPKO Health) Shiller PE Ratio

: (As of Today)
View and export this data going back to 1995. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


OPKO Health Shiller PE Ratio Historical Data

The historical data trend for OPKO Health's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OPKO Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Diagnostics & Research subindustry, OPKO Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health Shiller PE Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Shiller PE Ratio falls into.



OPKO Health Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

OPKO Health's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, OPKO Health's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.09/129.4194*129.4194
=-0.090

Current CPI (Dec. 2023) = 129.4194.

OPKO Health Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.110 99.695 -0.143
201406 -0.060 100.560 -0.077
201409 -0.110 100.428 -0.142
201412 -0.120 99.070 -0.157
201503 -0.260 99.621 -0.338
201506 -0.090 100.684 -0.116
201509 0.180 100.392 0.232
201512 0.003 99.792 0.004
201603 -0.020 100.470 -0.026
201606 0.020 101.688 0.025
201609 -0.030 101.861 -0.038
201612 -0.040 101.863 -0.051
201703 -0.060 102.862 -0.075
201706 -0.040 103.349 -0.050
201709 -0.060 104.136 -0.075
201712 -0.380 104.011 -0.473
201803 -0.080 105.290 -0.098
201806 -0.010 106.317 -0.012
201809 -0.050 106.507 -0.061
201812 -0.130 105.998 -0.159
201903 -0.140 107.251 -0.169
201906 -0.100 108.070 -0.120
201909 -0.110 108.329 -0.131
201912 -0.180 108.420 -0.215
202003 -0.090 108.902 -0.107
202006 0.050 108.767 0.059
202009 0.040 109.815 0.047
202012 0.050 109.897 0.059
202103 0.050 111.754 0.058
202106 -0.030 114.631 -0.034
202109 0.040 115.734 0.045
202112 -0.110 117.630 -0.121
202203 -0.080 121.301 -0.085
202206 -0.140 125.017 -0.145
202209 -0.110 125.227 -0.114
202212 -0.110 125.222 -0.114
202303 -0.020 127.348 -0.020
202306 -0.030 128.729 -0.030
202309 -0.110 129.860 -0.110
202312 -0.090 129.419 -0.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OPKO Health  (NAS:OPK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


OPKO Health Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of OPKO Health's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (OPKO Health) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D director 4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel director, officer: Chief Innovation Officer C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni director, officer: Vice Chairman and President 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli director, other: Chairman of the Board OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin director OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen director, officer: SVP OPKO; Exec Chairman BRLI C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman director 4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel director 1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez officer: CAO, Treasurer C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour director 19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal officer: Exec.Dir .of Fin., CAO,Treas. OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137